Pulmonary arterial hypertension is a rare, but deadly complication of systemic lupus erythematosus. French investigators sought to identify clinical features of patients with both.
A study in the VA system found that only 19% of patients diagnosed with pulmonary hypertension received a PDE5 iinhibitor prescription consistent with clinical guidelines.
Results of a new study identify specific clinical characteristics linked to poor quality of life in patients with PAH.
Right ventricular response to exercise may be used as a better indicator of ventricular-arterial coupling than resting hemodynamics, say authors of this new study.
Methamphetamine abuse is on a steady rise in the US. A new study highlights the nature and dangers of Meth-PAH.
Pulmonary hypertension is a common complication of CHD but a new Danish study is the first to report on population-based incidence and impact.
Pulmonary arterial hypertension is often complicated by atrial arrhythmias; a new study sheds light on the clinical impact.
Results of a subgroup analysis from the GRIPHON trial are promising for a hard-to-treat population.
Results of a new study suggest that stroke volume index may be the better hemodynamic variable to monitor in PAH – not cardiac index.
A new study finds that the first treatment chosen to treat PAH may help mitigate the burden of all-cause cost of care.